Literature DB >> 34904411

Basophils as a potential therapeutic target in cancer.

Jicheng Zhang1,2, Hanlin Yin1,2, Qiangda Chen1,2, Guochao Zhao1,2, Wenhui Lou1,2, Wenchuan Wu3,4, Ning Pu5,6.   

Abstract

Basophils, which are considered as redundant relatives of mast cells and the rarest granulocytes in peripheral circulation, have been neglected by researchers in the past decades. Previous studies have revealed their vital roles in allergic diseases and parasitic infections. Intriguingly, recent studies even reported that basophils might be associated with cancer development, as activated basophils synthesize and release a variety of cytokines and chemokines in response to cancers. However, it is still subject to debate whether basophils function as tumor-protecting or tumor-promoting components; the answer may depend on the tumor biology and the microenvironment. Herein, we reviewed the role of basophils in cancers, and highlighted some potential and promising therapeutic strategies.

Entities:  

Keywords:  Basophil; Cancer; Chemokine; Cytokine; Tumor microenvironment

Mesh:

Substances:

Year:  2021        PMID: 34904411      PMCID: PMC8669329          DOI: 10.1631/jzus.B2100110

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  116 in total

1.  Regulatory T cells induce activation rather than suppression of human basophils.

Authors:  Meenu Sharma; Mrinmoy Das; Emmanuel Stephen-Victor; Caroline Galeotti; Anupama Karnam; Mohan S Maddur; Patrick Bruneval; Srini V Kaveri; Jagadeesh Bayry
Journal:  Sci Immunol       Date:  2018-05-25

2.  Basophils are essential initiators of a novel type of chronic allergic inflammation.

Authors:  Kazushige Obata; Kaori Mukai; Yusuke Tsujimura; Kenji Ishiwata; Yohei Kawano; Yoshiyuki Minegishi; Naohiro Watanabe; Hajime Karasuyama
Journal:  Blood       Date:  2007-04-04       Impact factor: 22.113

Review 3.  Th2 Cells in Health and Disease.

Authors:  Toshinori Nakayama; Kiyoshi Hirahara; Atsushi Onodera; Yusuke Endo; Hiroyuki Hosokawa; Kenta Shinoda; Damon J Tumes; Yoshitaka Okamoto
Journal:  Annu Rev Immunol       Date:  2016-11-28       Impact factor: 28.527

4.  IgE receptors on human basophils. Relationship to serum IgE concentration.

Authors:  F J Malveaux; M C Conroy; N F Adkinson; L M Lichtenstein
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

Review 5.  Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.

Authors:  Joseph A Clara; Cecilia Monge; Yingzi Yang; Naoko Takebe
Journal:  Nat Rev Clin Oncol       Date:  2019-12-02       Impact factor: 66.675

6.  IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.

Authors:  Molly D Smithgall; Michael R Comeau; Bo-Rin Park Yoon; Dawn Kaufman; Richard Armitage; Dirk E Smith
Journal:  Int Immunol       Date:  2008-06-11       Impact factor: 4.823

7.  The Notch signaling pathway promotes basophil responses during helminth-induced type 2 inflammation.

Authors:  Oyebola O Oyesola; Simon P Früh; Lauren M Webb; Elena Kamynina; Katherine M Still; Ravi K Patel; Seth A Peng; Rebecca L Cubitt; Andrew Grimson; Jennifer K Grenier; Tajie H Harris; Charles G Danko; Elia D Tait Wojno
Journal:  J Exp Med       Date:  2019-04-11       Impact factor: 14.307

8.  miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A.

Authors:  Simona Caporali; Adriana Amaro; Lauretta Levati; Ester Alvino; Pedro Miguel Lacal; Simona Mastroeni; Federica Ruffini; Laura Bonmassar; Gian Carlo Antonini Cappellini; Nadia Felli; Alessandra Carè; Ulrich Pfeffer; Stefania D'Atri
Journal:  J Exp Clin Cancer Res       Date:  2019-06-21

9.  IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils.

Authors:  Fabian Zellweger; Patrick Buschor; Gabriel Hobi; Daniel Brigger; Clemens Andreas Dahinden; Peter Matthias Villiger; Alexander Eggel
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

10.  Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner.

Authors:  Takouhie Mgrditchian; Tsolere Arakelian; Jérôme Paggetti; Muhammad Zaeem Noman; Elodie Viry; Etienne Moussay; Kris Van Moer; Stephanie Kreis; Coralie Guerin; Stephanie Buart; Caroline Robert; Christophe Borg; Philippe Vielh; Salem Chouaib; Guy Berchem; Bassam Janji
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-16       Impact factor: 11.205

View more
  3 in total

Review 1.  Autophagy and cancer treatment: four functional forms of autophagy and their therapeutic applications.

Authors:  Zhaoshi Bai; Yaling Peng; Xinyue Ye; Zhixian Liu; Yupeng Li; Lingman Ma
Journal:  J Zhejiang Univ Sci B       Date:  2022-02-15       Impact factor: 3.066

2.  The Prognostic Value of Multiple Systemic Inflammatory Biomarkers in Preoperative Patients With Non-small Cell Lung Cancer.

Authors:  Kai Wang; Qidi Zhao; Tao Yan; Deyu Guo; Jichang Liu; Guanghui Wang; Jiajun Du
Journal:  Front Surg       Date:  2022-04-04

Review 3.  Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer.

Authors:  Chie Kudo-Saito; Narikazu Boku; Hidekazu Hirano; Hirokazu Shoji
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.